Transcription of FSRH Guideline Progestogen-only Implant
{{id}} {{{paragraph}}}
Example: dental hygienist
FSRH Guideline Progestogen-only Implant
fsrh Guideline Progestogen-only Implant February 2021 | FSRHF aculty of Sexual & Reproductive Healthcare ( fsrh ) provided funding to the Clinical Effectiveness Unit (of the fsrh ) to assist them in the production of this Guideline , Progestogen-only Implant (February 2021).Published by the Faculty of Sexual & Reproductive Healthcare. Registered in England No. 2804213 and Registered Charity No. 1019969 Progestogen-only Implant first published in February Faculty of Sexual & Reproductive Healthcare February is granted to reproduce or transmit this document for non-commercial personal and non-commercial education use only . Commercial use of any kind, including copying, hiring and lending, is reproduction of the whole of this document must reproduce this copyright notice in its reproduction of a part of this document must include a statement that it is reproduced under licence from fsrh and the notice Copyright Faculty of Sexual & Reproductive Healthcare.
8.1 Medical eligibility 8 8.2 Assessment of factors that could affect contraceptive effectiveness 10 9 Non-contraceptive benefits associated with use of the etonogestrel implant 10 9.1 Dysmenorrhoea 10 9.2 Heavy menstrual bleeding 10 9.3 Endometriosis 11 9.4 Endometrial protection in polycystic ovary syndrome 11
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: